Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monika M Toma

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Leukemia|September 2, 2024
Star wars against leukemia: attacking the clonesMonika M Toma, Tomasz Skorski
Molecular Cancer Research : MCR|June 26, 2023
Simultaneous Targeting of DNA Polymerase Theta and PARP1 or RAD52 Triggers Dual Synthetic Lethality in Homologous Recombination-Deficient Leukemia CellsKatherine Sullivan-Reed, Monika M Toma, Malgorzata Drzewiecka, et al.
Biorxiv : the Preprint Server for Biology|October 16, 2024
DNA polymerase theta-mediated DNA repair is a functional dependency and therapeutic vulnerability in DNMT3A deficient leukemia cellsBac Viet Le, Umeshkumar Vekariya, Monika M Toma, et al.
Cell Reports. Medicine|March 18, 2026
Polθ activity modulates sensitivity to standard therapies in DNMT3A-deficient leukemiaBac Viet Le, Umeshkumar Vekariya, Monika M Toma, et al.
Molecular Cancer Therapeutics|December 8, 2023
4'-Ethynyl-2'-Deoxycytidine (EdC) Preferentially Targets Lymphoma and Leukemia Subtypes by Inducing Replicative StressMarissa L Calbert, Gurushankar Chandramouly, Clare M Adams, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Leukemia|September 2, 2024
Star wars against leukemia: attacking the clonesMonika M Toma, Tomasz Skorski
Molecular Cancer Research : MCR|June 26, 2023
Simultaneous Targeting of DNA Polymerase Theta and PARP1 or RAD52 Triggers Dual Synthetic Lethality in Homologous Recombination-Deficient Leukemia CellsKatherine Sullivan-Reed, Monika M Toma, Malgorzata Drzewiecka, et al.
Biorxiv : the Preprint Server for Biology|October 16, 2024
DNA polymerase theta-mediated DNA repair is a functional dependency and therapeutic vulnerability in DNMT3A deficient leukemia cellsBac Viet Le, Umeshkumar Vekariya, Monika M Toma, et al.
Cell Reports. Medicine|March 18, 2026
Polθ activity modulates sensitivity to standard therapies in DNMT3A-deficient leukemiaBac Viet Le, Umeshkumar Vekariya, Monika M Toma, et al.
Molecular Cancer Therapeutics|December 8, 2023
4'-Ethynyl-2'-Deoxycytidine (EdC) Preferentially Targets Lymphoma and Leukemia Subtypes by Inducing Replicative StressMarissa L Calbert, Gurushankar Chandramouly, Clare M Adams, et al.
Pageof 1